Clinical Trials on Hormone Refractory Prostate Cancer in United States
Total 6895 results
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Rahul AggarwalSanofiCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
George Washington UniversityTerminatedProstate AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
University of California, IrvineWithdrawnProstate LesionsUnited States
-
Albert DeNittisUnknown
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
MANA RBMBayer; Tulane University; Barbara Ann Karmanos Cancer Institute; Carolina Urologic...TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate CancerUnited States
-
BayerCompleted
-
Dizal PharmaceuticalsTerminatedMetastatic Castration Resistant Prostate CancerUnited States, Korea, Republic of
-
Michael EvansNational Institute of Mental Health (NIMH); U.S. Army Medical Research Acquisition...RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Thomas HopeGateway for Cancer Research; Prostate Cancer Foundation; Conquer Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Imperial College LondonWellcome Trust; Imperial Clinical Trials Unit (ICTU)CompletedProstate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Metastatic Prostate Carcinoma in the Soft Tissue | Non-metastatic Prostate CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Mayo ClinicRecruitingBiochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate AdenocarcinomaUnited States
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbCompletedProstate Cancer | Recurrent Prostate Carcinoma | Stage IV Prostate AdenocarcinomaUnited States
-
Portland VA Medical CenterCompletedProstate Cancer | Hereditary Prostate CancerUnited States
-
University of MiamiCompletedProstate Cancer | Prostate Adenocarcinoma | Radiation ToxicityUnited States
-
Exact ImagingCompletedProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateCanada, United States
-
Accelerated Community Oncology Research NetworkBayerTerminatedMetastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIA Prostate Cancer AJCC v7 | PSA Level Less Than Ten | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7 | Stage II Prostate Cancer AJCC v7 | PSA Level Less Than or Equal to FifteenUnited States
-
Opna-IO LLCTerminatedMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
University of ChicagoActive, not recruitingProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Cancer | Stage IV Prostate CancerUnited States
-
City of Hope Medical CenterTerminatedProstate Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Male Erectile DisorderUnited States
-
Jonsson Comprehensive Cancer CenterActive, not recruitingStage III Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Infinity Pharmaceuticals, Inc.CompletedProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
OHSU Knight Cancer InstitutePfizerTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Virginia Commonwealth UniversityWithdrawnProstate CancerUnited States
-
National Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
National Cancer Institute (NCI)Active, not recruitingSolid Tumor | Prostate Cancer | Advanced Solid Tumor | Metastatic Prostate Cancer | Prostate NeoplasmUnited States
-
University of California, San FranciscoCompletedMen With Prostate Cancer Undergoing Robot Assisted Radical ProstatectomyUnited States
-
UNC Lineberger Comprehensive Cancer CenterWake Forest University Health SciencesCompletedCastration-resistant Prostate Cancer | Androgen Deprivation TherapyUnited States
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Gilead SciencesTerminatedMetastatic Castrate-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States
-
Bavarian NordicCompletedAndrogen-insensitive Prostate CancerUnited States
-
University of UtahGenentech, Inc.; Bavarian NordicWithdrawnProstate AdenocarcinomaUnited States
-
Athenex, Inc.CompletedBone-Metastatic, Castration-Resistant Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.RecruitingMetastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian CarcinomaUnited States
-
Lawrence FongGenentech, Inc.RecruitingProstate Cancer | Prostate Adenocarcinoma | Localized Prostate CancerUnited States
-
Mayo ClinicNot yet recruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States